Company Filing History:
Years Active: 2024
Title: Justin M David: Innovator in Targeting Treg Cells
Introduction
Justin M David is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of immunology, particularly in the targeting of regulatory T cells (Treg cells). His innovative work has the potential to impact therapeutic strategies in various medical conditions.
Latest Patents
Justin M David holds a patent for "Methods and compositions for targeting Treg cells." This patent describes the antibody NEO-201, which is shown to bind to Treg cells. The patent outlines its use in isolating, detecting, or purifying active Treg cells, as well as its potential to kill Treg cells. Additionally, therapeutic methods and combination therapies using NEO-201, optionally in combination with another agent, are described.
Career Highlights
Justin M David is currently associated with Precision Biologics, Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new avenues for immunotherapy and enhancing treatment options for patients.
Collaborations
He collaborates with esteemed colleagues, including Philip M Arlen and Kwong Y Tsang, who contribute to the innovative research environment at Precision Biologics, Inc.
Conclusion
Justin M David's contributions to the field of immunology through his patent on targeting Treg cells exemplify his commitment to advancing medical science. His work holds promise for future therapeutic applications and highlights the importance of innovation in healthcare.